Making
prescriptions
personal

About OneOme

OneOme, co-founded by Mayo Clinic, is working to deliver the most comprehensive, cost-effective pharmacogenomic testing and tools for all providers across the globe to use in everyday patient care. By increasing adoption of pharmacogenomics, OneOme may help providers make better prescription decisions, protect patients from adverse drug reactions and drug ineffectiveness, and reduce healthcare costs.

Awards

  • fast company logo
  • tekne logo
  • eureka logo
  • medical alley logo

Company news

OneOme Expands its Comprehensive Pharmacogenomic Test Offering with New Genes and Medications

05/22/2018

MINNEAPOLIS (MAY 22, 2018) — OneOme, co-developed by Mayo Clinic, today announced several significant enhancements to its product offering, including the addition of four new genes (HLA-A, HLA-B, CYP4F2, and CYP2C Cluster) and nine new medications ...

READ MORE

OneOme Named One of the World’s 50 Most Innovative Companies for 2018 by Fast Company

02/20/2018

MINNEAPOLIS (February 20, 2018) – OneOme, a healthcare technology company whose genetic test helps predict how a person will respond to hundreds of medications and enables healthcare providers to prescribe more effective medications, today announced that it is included in Fast Company’s annual ranking of the 50 Most Innovative Companies for 2018.

READ MORE

Patients Can Now Request a OneOme RightMed® Test Through an Independent Provider Network

01/10/2018

MINNEAPOLIS (January 10, 2018) – Precision medicine company OneOme is partnering with PWNHealth to increase patient access to the RightMed® comprehensive test without compromising patient safety.

READ MORE

OneOme Wins 2017 Tekne Award in Healthcare

11/16/2017

MINNEAPOLIS (November 16, 2017) – Last night, OneOme was awarded a Tekne Award in Healthcare at the 18th Annual Minnesota High Tech Association (MHTA) Tekne Awards. The Tekne Awards honor companies and individuals in Minnesota who have demonstrated superior technology innovation ...

READ MORE

Concierge Medicine Forum Features OneOme Expert on Pharmacogenomics

10/26/2017

MINNEAPOLIS (October 26, 2017) – The Concierge Medicine Forum held this week in Atlanta will feature an expert on pharmacogenomics from OneOme, a leading precision medicine company. Ryan Gregg, Ph.D, medical science liaison from OneOme, will present a session on pharmacogenomics ...

READ MORE

In Singapore, OneOme and Tucker Medical Partner to Improve Preventive Care and Oncology Treatments

10/11/2017

SINGAPORE, MINNEAPOLIS (October 11, 2017) – In Singapore, OneOme and Tucker Medical are working together to help improve preventive care and oncology treatments. OneOme is a leader in pharmacogenomic testing and Tucker Medical is a multi-specialty practice offering personalized medicine and ...

READ MORE

Investment opportunities

If you are interested in being a part of the future of precision medicine and would like to discuss investment opportunities with OneOme, please contact us at investorrelations@oneome.com.

People of OneOme

Leadership Toggle icon

  • Paul Owen

    PAUL OWEN — CHIEF EXECUTIVE OFFICER

    Paul joined OneOme as its President and COO in August 2015 and became CEO in June of 2016. Prior to OneOme, Paul led global commercialization for Invitae, a San Francisco-based hereditary disease diagnostics company that is listed on the New York Stock Exchange and that raised over $120Million in capital during Paul’s tenure. Prior to Invitae, Paul served as Vice Chair of Global Business Development for Mayo Clinic and was the leader of Mayo Medical Laboratories’ global commercial team – one of the world’s largest full-service reference labs. Prior to that, Paul held leadership roles at what is now Zimmer-Biomet and at Boston Scientific, both highly competitive, cutting-edge, and fast-paced organizations. Paul received his B.S. in business administration from the University of Wisconsin – Stout.

  • Jason Ross

    Jason Ross — CHIEF TECHNOLOGY OFFICER

    Jason is the Chief Technology Officer with over 20 years of Healthcare Information Technology experience. Prior to joining OneOme, Jason held the position of IT Section Head at Mayo Clinic and was responsible for leading their IT strategy for genomics, informatics and advanced analytics. In addition, he was the Associate Director of IT for Mayo Clinic’s Center for Individualized Medicine. Jason holds a B.S. in molecular biology from University of Wisconsin – Eau Claire and a M.A. in Healthcare Administration from St. Mary’s University of Minnesota.

  • Mark Sylvester

    MARK SYLVESTER — CHIEF FINANCIAL OFFICER

    Mark is currently the Chief Financial Officer (CFO) for OneOme and Invenshure, LLC. Previously, Mark was the CFO at The Emily Program, where he oversaw accounting, finance, payroll, and financial analytics. During his tenure, Mark sat on the board of directors, was a member of the senior leadership team, structured a debt and equity recapitalization, and was instrumental in business development during a period of rapid growth. Mark received his J.D. from the University of St. Thomas School of Law and B.A. from Saint John’s University.

  • Brian Arendt

    BRIAN ARENDT — SENIOR DIRECTOR OF COMMERCIAL OPERATIONS

    Brian joined OneOme as the Director of Commercial Operations in October 2015. Previously, he held management roles in operations, analytics, and IT for a genetic information company, diagnostic reference laboratory, and an integrated health system. Brian has a B.S. in marketing from Winona State University and an M.B.A. from the University of Wisconsin — La Crosse.

  • Don Skifter

    DON SKIFTER — VICE PRESIDENT OF GLOBAL SALES

    Don joined the OneOme team in May of 2016 as Director of East Sales and after making significant progress advancing OneOme's commercial efforts was subsequently promoted to Vice President of North American Sales and Business Development. Don has spent the past 15 years of his career in various commercial roles within genetic technology and services sectors including roles most recently at the Broad Institute where he helped launch Broad Genomic Services and at Complete Genomics, Sequenom, and Invitrogen/Life Technologies/Thermo Fisher prior to that. Don received his PhD in pharmacology and neuroscience from the University of Nebraska Medical Center and his MBA from the University of Nebraska Omaha.

  • Jason Sheard

    JASON SHEARD — SENIOR DIRECTOR OF PRODUCT DEVELOPMENT

    Jason is the Director of Product Development at OneOme. He is also the Director of Operations at Invenshure, LLC and is a technical leader with diverse product development experience, outstanding customer and engineering management skills, and a proven ability to build consensus and motivate teams to excel. Previously, he was the Vice President of Products for Logic PD, and before that he was Director of Electrical Engineering. Jason has a B.S. in physics from Bethel University and an M.S. in mechanical engineering from the University of Minnesota — Twin Cities.

  • Bronwyn Hartung

    BRONWYN HARTUNG, PhD — LABORATORY DIRECTOR

    Bronwyn is the founder of Phoenix Laboratory Consulting, based in Prospect, Kentucky. She has 15 years of experience in molecular genetics, with expertise in the design and validation of laboratory-developed tests, high-complexity clinical laboratory operations, quality systems, regulatory compliance, and medical device software. Her pharmacogenetics specialties include CYP450 haplotype and copy number analysis, data interpretation, and reporting. She earned her B.S. in Biology at Trinity University and her Ph.D. at Indiana University, followed by a postdoctoral fellowship in microbial pathology at the University of Iowa.

  • Ross Higgins

    ROSS HIGGINS — SENIOR DIRECTOR OF LABORATORY OPERATIONS & CLINICAL DEVELOPMENT

    Ross Higgins joined OneOme in early 2016 and holds responsibility for organizing and directing laboratory operations for the company. Most recently, Ross served in a dual business development and product management role for Douglas Scientific, where he was responsible for driving both product development and market expansion efforts. Ross also brings extensive experience in the clinical laboratory field, owing to several years managing the molecular genetics department at a large, CAP-accredited reference laboratory. Ross has a B.S. in Clinical Laboratory Sciences and an M.B.A. from Virginia Commonwealth University. He also maintains ASCP certification as a Medical Laboratory Scientist.

  • Mark Billmayer

    MARK BILLMAYER — SENIOR DIRECTOR OF PGX PROGRAM DEVELOPMENT

    Mark leads pharmacogenomics program development for OneOme, focusing on plan sponsors and PBMs. He has worked in many facets of healthcare including health plans, hospitals and clinics, PBMs, pharmacies, consulting and marketing firms, and technology startups. Most recently, Mark served as Director of Product Development within Specialty Pharmacy for OptumRx. Previously, with Intellogy Health Designs, he consulted on a wide variety of projects with US Oncology, Teradata, Fujitsu, McKesson/Relay Health, Rocky Mountain Cancer Centers and more. Mark received his B.S. in health and medical marketing from the University Wisconsin-Superior.

Board Members

  • Troy Kopischke

    TROY KOPISCHKE — CO-FOUNDER AND CHAIRMAN OF THE BOARD

    Troy is the co-founder and chairman of the board of OneOme. He is also a co-CEO, co-founder, and managing partner of Invenshure. Previously, he was the President and Chief Financial Officer at Steady State Imaging, where he was instrumental in developing a commercialization strategy that helped guide the sale of the company to GE Healthcare in 2011. Troy holds a B.S. in electrical engineering from the University of Minnesota as well as a B.A. in physics and a B.A. in engineering science from Bethel College.

  • Paul Owen

    PAUL OWEN — CHIEF EXECUTIVE OFFICER

    Paul joined OneOme as its President and COO in August 2015 and became CEO in June of 2016. Prior to OneOme, Paul led global commercialization for Invitae, a San Francisco-based hereditary disease diagnostics company that is listed on the New York Stock Exchange and that raised over $120Million in capital during Paul’s tenure. Prior to Invitae, Paul served as Vice Chair of Global Business Development for Mayo Clinic and was the leader of Mayo Medical Laboratories’ global commercial team – one of the world’s largest full-service reference labs. Prior to that, Paul held leadership roles at what is now Zimmer-Biomet and at Boston Scientific, both highly competitive, cutting-edge, and fast-paced organizations. Paul received his B.S. in business administration from the University of Wisconsin – Stout.

  • Jeremy Friese

    JEREMY FRIESE, M.D.

    Jeremy is managing partner at Invenshure, an early-stage venture firm based in Minneapolis, and helped launch OneOme, for which he now serves as a director. He is an active investor and board member in the diagnostics and genomics arenas. Jeremy was an interventional radiologist at Mayo Clinic, where he also served as Associate Chair of the Department of Radiology and ran business development for Mayo Global Business Solutions. Jeremy earned his M.D. at Mayo Medical School and completed surgery and radiology training at Mayo Clinic and Harvard Medical School. He earned his M.B.A. from Harvard Business School.

  • Danny Cunagin

    DANNY CUNAGIN

    Danny Cunagin is Co-CEO of Invenshure, a venture catalyst that identifies, incubates, funds and grows emerging technology companies ready for commercialization. He is acting CEO of Invenshure’s portfolio companies in medical imaging and biotechnology and previously was the Chief Executive Officer and Chairman of the Board of Steady State Imaging and was CEO, Chairman, and majority owner of Logic Product Development. He was noted as one of “forty under 40” in 1999 by City Business, and has a B.S.M.E. from the University of Kentucky.

Advisors

  • John Black

    JOHN L. BLACK III, M.D. — MAYO CLINIC, CO-FOUNDER ONEOME

    John L. Black III, M.D. is one of the co-founders of OneOme and also a consultant in the Division of Clinical Biochemistry and Immunology with a joint appointment in the Department of Psychiatry and Psychology at Mayo Clinic in Rochester. He joined the staff of Mayo Clinic in 1985 and is currently the co-director of the Personalized Genomics Laboratory. He received his B.A. and M.S. in psychology from the University of Wyoming. He received his M.D. (cum laude) from Creighton University School of Medicine. He is board certified in general, geriatric, and addiction psychiatry and is a clinical chemist.

  • Liewei Wang

    LIEWEI WANG, M.D., Ph.D. — MAYO CLINIC, Co-founder OneOme

    Dr. Wang is a professor in the Department of Molecular Pharmacology and Experimental Therapeutics (MPET) at Mayo Clinic Rochester. Her research involves the application of high-throughput "omics" technologies to identify biomarkers that might help us individualize cancer therapies, understand mechanisms of drug action, and facilitate target identification and drug development. She is also a co-leader of the Mayo Pharmacogenomics Program within the Mayo CIM, where many of the projects involving personalized medicine have been conducted. She is the co-PI for the Mayo-NIH clinical pharmacology T32 training grant and the Associate Director for the Mayo MPET graduate program.

  • Richard Weinshilboum

    RICHARD WEINSHILBOUM, M.D. — MAYO CLINIC, Co-founder OneOme

    Dr. Weinshilboum received B.A. and M.D. degrees from the University of Kansas, followed by residency training in internal medicine at the Massachusetts General Hospital. He was also a pharmacology Research Associate at the National Institutes of Health (NIH). He began his affiliation with the Mayo Medical School and Mayo Clinic in 1972, where he is presently Professor of Pharmacology and Medicine and Mary Lou and John H. Dasburg Professor of Cancer Genomics Research. He currently directs the Pharmacogenomics Program of the Mayo Center for Individualized Medicine and is co-Principal Investigator of the long-standing US NIH Pharmacogenomics Research Network Center at the Mayo Clinic.

  • Paldeep S. Atwal, M.B., Ch.B. - Advisory Board Member

    Paldeep S. Atwal, M.B., Ch.B. - Advisory Board Member

    Dr. Atwal is a board-certified clinical and medical biochemical geneticist who formerly served at Mayo Clinic’s Jacksonville campus as medical director for the Center for Individualized Medicine and clinical lead for the Department of Clinical Genomics. He is a fellow of both The American College of Medical Genetics & Genomics and The Royal Colleges of Physicians of the United Kingdom. He received his medical degree from the University of Glasgow, Scotland and initially trained in hospital internal medicine with The Royal College of Physicians at Glasgow Royal Infirmary and various other hospitals around the Glasgow area. He completed his medical genetics residency at Stanford University Medical Center in Palo Alto, CA and his sub-specialty medical biochemical genetics fellowship at Baylor College of Medicine in Houston, TX. Additionally, he holds diplomas in Structural Molecular Biology and Forensic Medical Science.

  • Christopher Bojrab, MD - Advisory Board Member

    Christopher Bojrab, MD - Advisory Board Member

    Dr. Chris Bojrab is president of Indiana Health Group, the largest multidisciplinary behavioral health private practice in Indiana, established in 1987. He is a board certified psychiatrist and a Distinguished Fellow of the American Psychiatric Association who treats child, adolescent, adult, and geriatric patients. His areas of interest include psychopharmacology, mood and anxiety disorders, ADHD, sleep disorders, pain syndromes, and gambling addiction. After graduating from Wabash College, Dr. Bojrab received his M.D. degree from the Indiana University School of Medicine where he also completed his residency and served as chief resident. Dr. Bojrab is a past president of the Indiana Psychiatric Society and has served on the Board of Directors for Mental Health America of Indiana. He has also served as a delegate to the American Medical Association and as Indiana’s representative to the American Psychiatric Association for several years.

  • Bernard Esquivel, MD, MHA, PhD - Advisory Board Member

    Bernard Esquivel, MD, MHA, PhD - Advisory Board Member

    Bernard Esquivel MD, MHA, Ph.D., is the CEO of Total Quality Medicine (TQM), a Mexico-based leader in health-related services and products, including GeneTest. GeneTest is a division of TQM that provides a range of services and testing to personalize medical treatments through the development, design, and improvement of genetic testing. He also is the CEO of Genomedik, a personalized medicine clinic in Guadalajara, and is the medical director at Boutique Hospital Rio Bamba in Mexico City. Dr. Esquivel received his medical degree with a specialty in clinical immunology and allergies from the National Autonomous University of Mexico. He also completed post-graduate work in medical genetics at the University of Valencia, Spain, and has a certificate in pediatric clinical immunology and allergies from San Juan de Dios Hospital. Dr. Esquivel is the current president of the Latin American Association of Personalized Medicine.

  • Carmen Kosicek, MSN, PMHNP - Advisory Board Member

    Carmen Kosicek, MSN, PMHNP - Advisory Board Member

    Carmen Kosicek, RN, MSN is the CEO & founder of Alay Health Team, a psychiatric clinic caring for children and adults both on-site and via telemedicine. She is also the clinical medical director at Dodge County Bridges, a nonprofit committed to providing supervised residential and support services to adult clients transitioning from rehabilitation to recovery from substance abuse. Carmen’s healthcare career has spanned clinical positions in nuclear medicine, labor and delivery BSN-RN in women’s health, OB nurse manager, and as an advanced practice nurse-midwife. She has 10+ years of experience teaching across an array of LPN, ADN, and BSN levels. Carmen received an Associate of Applied Science in Nuclear Medicine from Triton College, a Bachelor of Science in Nursing from the University of St. Francis, a Master of Science in Nursing from Case Western Reserve University, and a postgraduate certificate as an advanced practice nurse in nurse-midwifery at Frontier University.

  • Jeanette McCarthy, MPH, PhD - Advisory Board Member

    Jeanette McCarthy, MPH, PhD - Advisory Board Member

    As a genome scientist, Jeanette McCarthy, MPH, PhD spent years doing research on the genetic underpinnings of complex diseases, both infectious and chronic, and working to advance the field of precision medicine. More recently, Dr. McCarthy turned her attention to educating stakeholders in the field. She believes informed consumers will play a major role in their health care going forward. In 2014, Dr. McCarthy helped launch the first consumer-facing magazine in this field, Genome, where she was founding editor-in-chief. Dr. McCarthy has developed courses in precision medicine at UC Berkeley Extension and through UCSF via Coursera. She also designs and delivers workshops, symposia and webinars on more general, as well as technical topics, related to precision medicine through her consulting business, Precision Medicine Advisors and the Precision Medicine Foundation.

  • Jeffrey S. Puglisi, MD - Advisory Board Member

    Jeffrey S. Puglisi, MD - Advisory Board Member

    Dr. Puglisi, board certified in internal medicine, is a founding partner of Glenville Medical Concierge Care. Dr. Puglisi’s specialized clinical interests are in men’s health and cardiovascular disease prevention. He has served as president of the Greenwich Medical Society since 2006 and was recognized as a finalist for the Melville G. Magida Humanitarian Award in 2010. He earned his undergraduate degree from Franklin & Marshall College, medical degree from Hahnemann University School of Medicine, and completed his residency in internal medicine at Mount Sinai Hospital in New York, where he served as chief resident.

  • Scott A. Storrer, MBA - Advisory Board Member

    Scott A. Storrer, MBA - Advisory Board Member

    Scott is responsible for the strategic development and expansion of the eHealth product line. A 25-year healthcare industry veteran, Scott brings deep, diverse and innovative experience in leading and growing healthcare businesses, having held senior management positions at Strand Life Sciences, a personalized medicine and biotechnology software solution provider and FirstLab, a third party administrator for substance abuse monitoring. Earlier in his career, Scott served as group president of Cardinal Health’s $81B pharmaceutical segment and executive vice president of Service and Technology for CIGNA.

  • Steven Tucker, MD, FACP, FAMS - Advisory Board Member

    Steven Tucker, MD, FACP, FAMS - Advisory Board Member

    While originally trained as a cancer specialist at the UCLA Center for Health Sciences, Dr. Tucker currently focuses on both adult general medicine and cancer medicine. Dr. Tucker is also an expert in medical technology and digital health. By studying information from multiple sources, such as personal genetics, metabolic testing, sensors and activity trackers, he helps patients develop personalized health plans that combine the elements of behavioral change with those of conventional medicine, as necessary. Dr. Tucker has received numerous honors and awards including a prestigious Merit Award from the American Society of Clinical Oncology and a Commendation from the U.S. National Institutes of Health. Dr. Tucker is a fellow of the American College of Physicians (FACP) and the Academy of Medicine, Singapore (FAMS), as well as an officer of the Chapter of Medical Oncologists, College of Physicians Singapore (CPS).

Team Toggle icon

Ben Metzger

Software Development

Ben
Metzger

Brett Miller

Sales

Brett
Miller

Catie Pfeilsticker

Laboratory Operations

Catie
Pfeilsticker

Colin Pistulka

Commercial Operations

Colin
Pistulka

Colleen Owen

Human Resources

Colleen
Owen

Erica Schnettler

Medical Affairs

Erica
Schnettler

Erik Anderson

IT

Erik
Anderson

Erin Rech

Business Development

Erin
Rech

Grant Williams

Sales

Grant
Williams

Hennessy McIlvaine

Clinical Development

Hennessy
McIlvaine

Jacob Sevlie

Software Development

Jacob
Sevlie

Jake Comstock

Business Development

Jake
Comstock

Jeff Driscoll

Business Development

Jeff
Driscoll

Jordan Gutzman

Sales

Jordan
Gutzman

Kathleen Bosse

Clinical Development

Kathleen
Bosse

Katie Mittelstadt

Marketing

Katie
Mittelstadt

Kesah Schmitt

Marketing

Kesah
Schmitt

Kirsten Bauer

Laboratory Operations

Kirsten
Bauer

Kurt Wiersma

Software Development

Kurt
Wiersma

Lilly Drew

Commercial Operations

Lilly
Drew

Linda McDowell

Business Development

Linda
McDowell

Lydia Kantor

Marketing

Lydia
Kantor

Matt Hilden

Software Development

Matt
Hilden

Megan Adelman

Clinical Development

Megan
Adelman

Morgan Donaldson

Business Development

Morgan
Donaldson

Preston Anderson

Sales

Preston
Anderson

Ryan Gregg

Medical Affairs

Ryan
Gregg

Sam Fortin

Marketing

Sam
Fortin

Steve Sheldon

IT

Steve
Sheldon

Tyler Koep

Medical Affairs

Tyler
Koep

Vaishnavi Soundararajan

Clinical Development

Vaishnavi
Soundararajan

Vince Catania

Business Development

Vince
Catania

Wrenda Teeple

Clinical Development

Wrenda
Teeple